baricitinib - Robuta Search

https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1264496/full

Frontiers | Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin...

Solid organ transplant represents a potentially lifesaving procedure for patients suffering from end-stage heart, lung, liver, and kidney failure. However, ...

graft rejection frontiers baricitinib cyclosporine acute

https://www.pharmaceutical-technology.com/news/lilly-eva-baricitinib-africa/

Lilly and EVA Pharma to expand baricitinib access in Africa

Eli Lilly and EVA Pharma have formed a partnership to increase the availability of baricitinib in 49 African countries by 2030.

lilly eva pharma expand baricitinib

https://pubmed.ncbi.nlm.nih.gov/33001140/

Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate...

ClinicalTrials.gov Identifier: NCT03733301.

topical corticosteroids efficacy safety baricitinib combined

https://www.jci.org/articles/view/179436

JCI - Rapid response of lichen planus to baricitinib associated with suppression of cytotoxic...

rapid response lichen planus jci baricitinib associated

https://www.pharmaceutical-technology.com/news/lilly-incyte-baricitinib-study/

Lilly and Incyte report Phase III trial results of baricitinib in Covid-19 patients

Eli Lilly and Incyte have reported that the Phase III COV-BARRIER study of baricitinib failed to meet primary endpoint in Covid-19 patients.

phase iii trial lilly incyte report results